Watch CORT. Know when insiders buy.
One email the day a filing lands. Free.
Work order
39
FLAG · insiders 25, shorts 53
Insiders, 90 days
−$28.7M
net selling · 0 buys, 17 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
2 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $12.1BP/E 265.8DIV YIELD —FCF YIELD 0.89%REV TTM $830.8M +16.0%NET INCOME $55.2M −58.7%NET CASH $77.1M52W 32.15 – 123.57NEXT EARNINGS Nov 4 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $256.1M | +31.7% | 98.4% | $41.3M | $43M | +22.3% | 0.36 | $33.5M | $2.5M | $31M | Jul 29 |
| Q1 2026 · Mar 31 | $164.9M | +4.9% | 98.3% | −$49.6M | −$31.8M | −254.6% | -0.30 | −$16.8M | $201K | −$17M | Jul 29 |
| Q4 2025 · Dec 31derived | $202.1M | +11.1% | 98.7% | $4.5M | $24.3M | −21.0% | 0.20 | $38.4M | $50K | $38.4M | Feb 24 |
| Q3 2025 · Sep 30 | $207.6M | +13.7% | 97.8% | $10.2M | $19.7M | −58.3% | 0.16 | $54.5M | $0 | $54.5M | Nov 4 |
| Q2 2025 · Jun 30 | $194.4M | +18.7% | 98.2% | $26.7M | $35.1M | −1.0% | 0.29 | $44.3M | $57K | $44.2M | Jul 29 |
| Q1 2025 · Mar 31 | $157.2M | +7.1% | 98.5% | $3.4M | $20.5M | −26.0% | 0.17 | $4.8M | $104K | $4.7M | Jul 29 |
| Q4 2024 · Dec 31derived | $181.9M | +34.3% | 98.4% | $25.3M | $30.7M | −1.9% | 0.25 | $60.1M | $121K | $59.9M | Feb 24 |
| Q3 2024 · Sep 30 | $182.5M | +47.7% | 98.4% | $46.6M | $47.2M | +50.5% | 0.41 | $73.3M | $1.6M | $71.7M | Nov 4 |
| Q2 2024 · Jun 30 | $163.8M | — | 98.5% | $35.6M | $35.5M | — | 0.32 | $41.2M | $416K | $40.8M | Nov 4 |
| Q1 2024 · Mar 31 | $146.8M | — | 98.3% | $29.5M | $27.8M | — | 0.25 | $23.8M | $0 | $23.8M | Nov 4 |
| Q4 2023 · Dec 31derived | $135.4M | — | 98.6% | $31.7M | $31.4M | — | 0.28 | $5.5M | $0 | $5.5M | Feb 24 |
| Q3 2023 · Sep 30 | $123.6M | — | 98.7% | $31.2M | $31.4M | — | 0.28 | $52.9M | $37K | $52.9M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $761.4M | 98.3% | $44.8M | $99.7M | 13.1% | 0.82 | $142M | $211K | $141.8M | $172.9M | — |
| FY2024 · to Dec 31 | $675M | 98.4% | $137M | $141.2M | 20.9% | 1.23 | $198.3M | $2.2M | $196.1M | $15.7M | — |
| FY2023 · to Dec 31 | $482.4M | 98.7% | $107.3M | $106.1M | 22.0% | 0.94 | $126.7M | $139K | $126.5M | $0 | — |
| FY2022 · to Dec 31 | $401.9M | 98.7% | $112.6M | $101.4M | 25.2% | 0.87 | $120.3M | $413K | $119.9M | $0 | — |
| FY2021 · to Dec 31 | $366M | 98.6% | $124.5M | $112.5M | 30.7% | 0.89 | $167.9M | $469K | $167.4M | — | — |
| FY2020 · to Dec 31 | $353.9M | 98.4% | $128.2M | $106M | 30.0% | 0.85 | $152M | $1.2M | $150.7M | $9.9M | — |
Every number comes from CORCEPT THERAPEUTICS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.